United Capital Partners Successfully Source Approval for $1.

1MM Sale Lease

Back for Biotechnology Entity

An internationally based customer in need of liquidity to fund USA operations uses assets at USA
location to approve a $1.1MM sale lease back facility.

Houston, TX, August 15, 2017 --(PR.com)-- Customer, a global fully integrated biotechnology company
dedicated to developing innovative cancer treatments, required bridge funding to an equity raise. The
customer had equipment located at their USA facility and used the appraisal value of their assets to secure
a sale lease back facility. The use of the debt proceeds would fund the USA facilities operational
expenses while the parent entity worked on closing a large equity raise. United Capital Partners worked
with an Investor that specializes in growth capital secured by hard assets to provide the approval.

About United Capital Partners: United Capital Partners works with a team of finance professionals with
an average twenty years of experience in funding equipment leasing, working capital loans, revolving
lines of credit and bridge debt. We work closely with each of our clients and investors to provide tailored,
innovative finance products to support their current and future capital requirements. United Capital
Partners can offer a wide array of products that will enable us to support emerging growth companies,
established businesses and companies that are working through trying times. Whether your business
needs a lease line of credit to support capital equipment acquisitions, working capital to support continued
growth, senior debt or mezzanine debt, United Capital has a solution for you.

Page 1/2
PR.com Press Release Distribution Terms of Use
Contact Information:
United Capital Partners
Jennifer Blake
713-907-0372
Contact via Email
unitedcapllc.com

Online Version of Press Release:

You can read the online version of this press release at: http://www.pr.com/press-release/726602

News Image:

Page 2/2
PR.com Press Release Distribution Terms of Use